Project description
A novel electrophysiological platform will foster drug discovery for brain diseases
Fields of science
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- medical and health sciencesbasic medicineneurologydementiaalzheimer
- medical and health sciencesbasic medicinephysiology
- medical and health sciencesbasic medicineneurologyparkinson
- social scienceseconomics and businessbusiness and managementemployment
Programme(s)
Funding Scheme
CSA - Coordination and support actionCoordinator
MAXWELL BIOSYSTEMS AG
Net EU contribution
€ 135 500,00
Address
Albisriederstrasse 253
8047 Zurich
Switzerland
8047 Zurich
Switzerland
See on map
Region
Schweiz/Suisse/Svizzera Zürich Zürich
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00